人工智能在PET/CT肺部结节、肺肿瘤及纵隔淋巴结表征中的应用
本文综述了人工智能(机器学习与深度学习)在FDG PET或PET/CT图像上用于肺结节早期检测与诊断、肺肿瘤及纵隔淋巴结表征的研究。检索PubMed、Embase及临床试验数据库共获得361项研究,最终纳入29项回顾性研究,无临床试验;其中22项评估标准机器学习方法,7项评估深度学习直接应用于PET或PET/CT图像。研究多报告阳性结果,但22项缺乏相关对照和/或独立测试,现有研究常样本量不足且缺乏临床相关对照。
要点
- 纳入29项回顾性研究,无临床试验,22项缺乏相关对照和/或独立测试。
- 22项评估标准机器学习(如支持向量机),7项评估深度学习直接用于PET/CT图像。
- 机器学习用于肺结节诊断、肺肿瘤及纵隔淋巴结表征多报告阳性结果。
核心结论
- 应用PET/CT特征和图像输入的机器学习方法诊断和表征肺癌是一个相对年轻但前景广阔的研究领域。
- 当前发表的研究常样本量不足,缺乏临床相关对照和/或独立测试。
研究设计与样本
- 综述类研究,检索PubMed、Embase和临床试验数据库,共获得361项研究,最终纳入29项回顾性研究,无临床试验。
- 采用改良版TRIPOD声明和PROBAST工具对纳入研究进行分析。
主要发现
- 29项研究中,22项评估标准机器学习方法(如支持向量机)基于影像特征,7项评估深度学习直接应用于PET或PET/CT图像。
- 研究主要报告机器学习方法用于诊断肺结节、表征肺肿瘤和纵隔淋巴结的阳性结果。
- 22项研究缺乏相关对照和/或独立测试。
局限性
- 纳入研究均为回顾性,无临床试验。
- 多数研究缺乏相关对照和/或独立测试,且样本量不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer is the leading cause of cancer related death around the world although early diagnosis remains vital to enabling access to curative treatment options. This article briefly describes the current role of imaging, in particular 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET/CT, in lung cancer and specifically the role of artificial intelligence with CT followed by a detailed review of the published studies applying artificial intelligence (ie, machine learning and deep learning), on FDG PET or combined PET/CT images with the purpose of early detection and diagnosis of pulmonary nodules, and characterization of lung tumors and mediastinal lymph nodes. A comprehensive search was performed on Pubmed, Embase, and clinical trial databases. The studies were analyzed with a modified version of the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) and Prediction model Risk Of Bias Assessment Tool (PROBAST) statement. The search resulted in 361 studies; of these 29 were included; all retrospective; none were clinical trials. Twenty-two records evaluated standard machine learning (ML) methods on imaging features (ie, support vector machine), and 7 studies evaluated new ML methods (ie, deep learning) applied directly on PET or PET/CT images. The studies mainly reported positive results regarding the use of ML methods for diagnosing pulmonary nodules, characterizing lung tumors and mediastinal lymph nodes. However, 22 of the 29 studies were lacking a relevant comparator and/or lacking independent testing of the model. Application of ML methods with feature and image input from PET/CT for diagnosing and characterizing lung cancer is a relatively young area of research with great promise. Nevertheless, current published studies are often under-powered and lacking a clinically relevant comparator and/or independent testing.
引用
- Krarup MMK, Krokos G, Subesinghe M, et al. Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT. Semin Nucl Med. 2020. PMID: 33509371. doi:10.1053/j.semnuclmed.2020.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。